Navigation Links
Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report
Date:8/24/2010

help to address the lack of novel antimicrobial compounds in the pipeline that is a growing problem in the face of rapidly emerging multidrug-resistant organisms.

The MCMSI would display a higher-risk tolerance than currently exists by the US government for these products and accept a longer time horizon.  The fund would operate independently and outside the government as a 501(c)(3) corporation or other similar alternative. In addition to its own investments, the MCMSI would leverage private capital, provide expert consultation, and link promising companies with potential partners in the private sector.  Secretary of HHS Kathleen Sebelius noted that the MCMSI enterprise is part of a new $1.9 billion effort to ensure the U.S. has a "nimble" and "flexible" system to produce drugs and vaccines against any national medical emergency, whether from a terrorist attack or natural disaster.

To view a full copy of the report, please visit:

https://www.medicalcountermeasures.gov/documents/MCMReviewFinalcover-508.pdf

About Restanza

Restanza is a novel oral once-a-day antibiotic that is in late stage development for the treatment of community acquired bacterial pneumonia (CABP) and biodefense pathogens including anthrax, plague and tularemia. It has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria including CA-MRSA and pathogens associated with respiratory tract infections and appears to be effective against penicillin-, macrolide- and fluoroquinolone-resistant bacteria. Restanza's demonstrated potency and ability to overcome bacterial resistance may be due to its mechanism of action resulting in specificity for its bacterial target. In addition to its utility in CABP, Restanza is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Annual Clinical Congress of the American College of Surgeons (ACS), ... will convene October 3-7 at the Walter E. Washington Convention ... that the ACS Clinical Congress has ever been held in ... a prime opportunity for writers, editors, and producers who cover ...
... Sept. 28 Millstone Medical Outsourcing announced today that the ... Memphis, TN, facility.  Perry C. Rothrock, III, MD, was hired ... will be to ensure the integrity of all processes involving ... Master Chief in the United States Navy, was hired as ...
Cached Medicine Technology:American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010 2Millstone Medical Outsourcing Makes Strategic Hires in Memphis 2
(Date:8/30/2014)... Acne is a common problem millions of American cope with every ... daily nuisance, for some, it can have a crippling impact on ... to dramatic mood swings and depression. , Those struggling with ... skin. In some cases, that can make the problem even worse. ... on a quest for clearer skin can now view acne ...
(Date:8/30/2014)... Insomnia causes disturbances in every aspect of life. ... insomnia and the steps often used to return back to ... the show at this link: Dr. Carol Francis Talk ... and will be podcasted at this link (Click Here) ... , "Insomnia causes countless unrecognized complications. Weight gain ...
(Date:8/30/2014)... Phoenix, AZ (PRWEB) August 30, 2014 ... experienced personal injury attorneys located throughout Arizona is pleased ... settlement. This is one specific example among many cases ... that clients are able to retain a greater portion ... case after case that providing a positive solution for ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... sleep knowing that, at any moment, her fever might ... order to keep me well aware of how she ... developed the TEMP ALARM to continuously monitor a child's ... develops a fever. This ensures that prompt medical care ...
(Date:8/30/2014)... "I had a handicapped friend who could not walk along ... Wetumpka, Ala. "In order to help her be able to ... up with a way for her to use her crutches ... patent-pending Deezers to allow crutches to be used on uneven ... or canes at the beach. The device reduces the risk ...
Breaking Medicine News(10 mins):Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2
... Nature , a paper authored by over 200 members ... of a Brave New World, a new era of personalised ... brings together leading cancer researchers from around the world, working ... common cancers - 500 genomes from each cancer type ...
... workers gauge patient,s state of mind, researchers say , ... psychological test has the potential to gauge how people ... into what their patients are thinking, a new study ... show whether people automatically associate things with each other. ...
... blood sugar without user involvement , WEDNESDAY, April 14 ... the latest design of an artificial pancreas for people ... causing low blood sugar (hypoglycemia). , Ideally, this type ... 1 diabetes from the insulin injections that many require ...
... ... director, Sandi Timmins. Under Timmins’ wing, the organization is taking major steps toward reinventing its ... , ... 13, 2010 -- The House Of Ruth Maryland today announced taking significant steps ...
... ... out January 2011 , ... Village, NV (PRWEB) April 14, 2010 -- McGraw-Hill, the global leader in business books for ... release January 2011. Tim Riesterer, CMO and SVP of Consulting and Products and Erik ...
... properties, making it possible to use this bulb for food ... of Catalua (UPC) and the University of Barcelona (UB) in ... International Journal of Food Science and Technology . "The ... onion make it a good candidate for use in food ...
Cached Medicine News:Health News:Personalized medicine for cancer patients in a new technology era 2Health News:Personalized medicine for cancer patients in a new technology era 3Health News:Personalized medicine for cancer patients in a new technology era 4Health News:Test May Measure Suicidal Tendencies 2Health News:Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality 2Health News:Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality 3Health News:Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality 4Health News:Maryland's Preeminent Domestic Violence Agency Announces New Organizational Changes 2Health News:Maryland's Preeminent Domestic Violence Agency Announces New Organizational Changes 3Health News:Maryland's Preeminent Domestic Violence Agency Announces New Organizational Changes 4Health News:McGraw-Hill Signs Corporate Visions Experts to Book Deal 2Health News:The onion, a natural alternative to artificial preservatives 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: